 Candriam Luxembourg S.C.A. increased its stake in shares of Akers Biosciences Inc NASDAQ:AKER by 123.9 in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 36,146 shares of the medical instruments suppliers stock after purchasing an additional 20,000 shares during the period. Candriam Luxembourg S.C.A. owned approximately 0.59 ... 